In 2020, COVID-19 caught the world by surprise—this should not have been the case. The pandemic revealed significant gaps in early warning capabilities to detect and respond to emerging pathogens before they cause global harm. Given the current situation, how can we leverage existing systems and emerging technologies to better characterize the various risk factors that could signal the next pandemic?
The current global infrastructure suffers from deep fragmentation, lack of coordination and collaboration, a need for sophisticated knowledge management, and virtually no sustained governmental and organizational commitment. This report from FasterCures, 'A Global Early Warning System for Pandemics: Mobilizing Surveillance for Emerging Pathogens', seeks to catalyze momentum and lay the framework for mobilizing a more rapid and nimble early warning system with robust global coordination.
We outline principles to help guide decision-making, highlight key considerations for success, and offer initial steps and immediate actions for realizing such a coordinated global system.
Related Content
-
Protecting Youth Online: Insights and Actions for Communities, Policymakers, and Organizations
The United States is facing a youth mental health crisis. Forty-two percent of high school students reported experiencing persistent feelings of sadness, including 29 percent of boys, 57 percent of girls, and 69 percent of LGBTQ+ students...Read Report -
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization – US Senate HELP Committee
Submitted electronically The Honorable Bernie Sanders Chairman HELP Committee United States Senate Washington, DC 20510 The Honorable Bill Cassidy, MD Ranking Member HELP Committee United States Senate Washington, DC 20510 The Honorable...Read LetterImageEsther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives. -
Learning from COVID-19: Reimagining Public-Private Partnerships in Public Health
The Milken Institute Center for Public Health leveraged our network of thought leaders to maximize learnings from the COVID-19 pandemic, focused on examining the private sector’s role and responsibility in supporting public health. This...Read Report -
Americans’ Obesity Weighs Down U.S. Economy by $1.4 Trillion
WASHINGTON—Obesity and excess weight is an expanding health problem for more than 60 percent of Americans, and a new study from the Milken Institute finds that it's a tremendous drain on the U.S. economy as well. The total cost to treat...Read Article -
Are Community Health Workers Saving Lives? A Longitudinal Analysis of State-Level Variation in Community Health Workforce
U.S. health care costs are increasing rapidly while health care outcomes and access vary significantly across the country. Community health workers (CHWs) serve as bridges between the health care system and underserved communities...Read Report11 11Ross Devol and Marlon Graf -
Envisioning the Future of the Pharmaceutical Supply Chain to Advance Public Health in the United States
The Milken Institute's Public Health work engages our network of thought leaders to understand what actions could be taken to make the pharmaceutical supply chain (PSC) more resilient and equitable to advance public health. This report...Read Report11
-
Milken Institute Future of Health Summit Opens Tomorrow, December 7
Albert Bourla, Anthony Fauci, Margaret Hamburg among 175+ speakers Washington, DC – Dec. 6, 2020 – The Milken Institute Future of Health Summit kicks off tomorrow, drawing more than 1,000 leaders from government, science, education...Read Article -
America's Obesity Crisis: The Health and Economic Costs of Excess Weight
This study calculates the prevalence and economic effects of diseases related to obesity and overweight in the United States. These costs are paid by individuals and their households, employers, government, and society. The prevalence of...Read Report11 11Hugh Waters and Marlon Graf -
Patients Most In Need Face Obstacles to Participating in Life-Saving Clinical Trials According to a New Milken Institute Report
June 24, 2024 (Washington, DC)— Clinical trials can provide the possibility to obtain novel treatments for conditions and diseases that are not yet commercially available. Yet, these lifesaving treatments are often difficult or impossible...Read ArticleImagePaul Guequierre
Director, Strategic CommunicationsPaul Guequierre is the director of strategic communications. In this role, he works to increase the profile of Milken Institute in the media, raise the visibility of issues important to the organization and its stakeholders, and expand the Institute's digital presence. -
Prescription for Biomedical Innovation: Recommendations for the New Administration
FasterCures has long been at the forefront of shaping the national focus on biomedical innovation, with a singular goal of saving lives by accelerating scientific advances for all patients. FasterCures has been instrumental in advocating...Read Report -
Medicare Drug Price Negotiation Program
Submitted electronically Dr. Meena Seshamani Deputy Administrator and Director, Center for Medicare Centers for Medicare & Medicaid Services US Department of Health and Human Services Baltimore, MD 21244 Re: Medicare Drug Price Negotiation...Read LetterImageEsther Krofah
Executive Vice President, Milken Institute HealthEsther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives. -
Innovative Financing for Global Health R&D
To overcome funding challenges, global health organizations and their donors have developed financing tools, such as the advance market commitment (AMC), debt buy-downs, and pooled funds from tax revenue, that blend capital from the public...Read Report